Health Catalyst (HCAT) Cost of Revenue (2018 - 2026)

Health Catalyst (HCAT) has 9 years of Cost of Revenue data on file, last reported at $35.3 million in Q1 2026.

• For the quarter ending Q1 2026, Cost of Revenue fell 18.26% year-over-year to $35.3 million; the trailing twelve-month figure through Mar 2026 stood at $98.2 million (down 42.42% YoY), and the FY2025 full-year result was $159.5 million, down 3.83% from the prior year.
• Cost of Revenue for Q1 2026 stood at $35.3 million, roughly flat from $35.3 million in the prior quarter.
• Across five years, Cost of Revenue topped out at $114.1 million in Q4 2023 and bottomed at $12.7 million in Q2 2024.
• The 5-year median for Cost of Revenue is $35.3 million (2026), against an average of $37.7 million.
• The widest annual swing landed in 2022, when Cost of Revenue soared 124.07%; it then plunged 66.06% in 2025.
• A 5-year view of Cost of Revenue shows it stood at $75.9 million in 2022, then jumped by 50.25% to $114.1 million in 2023, then slumped by 36.67% to $72.2 million in 2024, then tumbled by 51.13% to $35.3 million in 2025, then decreased by 0.01% to $35.3 million in 2026.
• The last three Cost of Revenue figures came in at $35.3 million (Q1 2026), $35.3 million (Q4 2025), and $14.4 million (Q3 2025), per Business Quant data.

Peer Comparison